XCUR - Exicure files Form 12b-25 for delay in filing quarterly report

Exicure (XCUR -25.6%) has filed a Form 12b-25 with U.S. SEC related to its quarterly report on Form 10-Q for the period ended Sep.30. The company is unable to file its report within the prescribed time period without unreasonable effort or expense. On Nov. 9, 2021, the Audit Committee of the Board was notified of a claim made by a former senior researcher regarding alleged improprieties that researcher claims to have committed with respect to the company’s XCUR-FXN preclinical program for the treatment of Friedreich’s ataxia. Exicure is currently unable to predict the timing or outcome of the investigation. The company expects to file its Q3 10-Q with the SEC as soon as practicable, and no later than the fifth calendar day following the prescribed due date.

For further details see:

Exicure files Form 12b-25 for delay in filing quarterly report